Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021
Corporate Participants:
Christopher DelOrefice — Vice President, Investor Relations
Joseph J. Wolk — Executive Vice President, Chief Financial Officer
Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals
Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health
Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices
Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer
Analysts:
Louise Chen — Cantor Fitzgerald Securities — Analyst
Larry Biegelsen — Wells Fargo Securities LLC — Analyst
Chris Schott — J.P. Morgan Securities LLC — Analyst
Bob Hopkins — BofA Securities, Inc. — Analyst
Joshua Jennings — Cowen and Company — Analyst
Terence Flynn — Goldman Sachs & Co. LLC — Analyst
Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst
Joanne Wuensch — Citi — Analyst
Jayson Bedford — Raymond James Financial Inc. — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Alibaba Group (BABA) Q2 2025 Earnings: Key financials and quarterly highlights
Alibaba Group Holding Limited (NYSE: BABA) reported its second quarter 2025 earnings results today. Revenue was $33.7 billion, up 5% year-over-year. Net income attributable to ordinary shareholders grew 58% to
AMAT Earnings: Applied Materials Q4 revenue and profit increase YoY
Applied Materials, Inc. (NASDAQ: AMAT) announced financial results for the fourth quarter of 2024, reporting an increase in revenue and adjusted earnings. Adjusted earnings of the semiconductor technology company increased
What to expect when Target (TGT) reports its Q3 2024 earnings results
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday. The stock has gained 9% over the past three months. The retailer is scheduled to report its earnings results for
Listen On
